Bright Angel Therapeutics’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Bright Angel Therapeutics focuses on the development of novel drugs for the treatment of drug-resistant and fungal infections. Read more

Bright Angel Therapeutics focuses on the development of novel drugs for the treatment of drug-resistant and fungal infections. Read more

CEO Avatar

President & CEO

Dominic Jaikaran

CEO Approval Rating

90/100

Founded:

2017

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Cidara is one of Bright Angel Therapeutics's top rivals. Cidara's headquarters is in San Diego, California, and was founded in 2012. Like Bright Angel Therapeutics, Cidara also competes in the Biotechnology industry. Cidara generates ∞% of Bright Angel Therapeutics's revenue.

Amplyx has been one of Bright Angel Therapeutics's top competitors. Amplyx was founded in 2006 in San Diego, California. Like Bright Angel Therapeutics, Amplyx also operates in the Biotechnology field. Amplyx generates $7M more revenue than Bright Angel Therapeutics.

Scynexis is one of Bright Angel Therapeutics's top competitors. Scynexis was founded in Jersey City, New Jersey} in 2000. Like Bright Angel Therapeutics, Scynexis also competes in the Biotechnology sector. Compared to Bright Angel Therapeutics, Scynexis generates $121K more revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $ < 1M a good estimate for Bright Angel Therapeutics's revenue?

Acquisitions

No recent acquisitions found related to Bright Angel Therapeutics

Bright Angel Therapeutics Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Seed
Dec 2019
--

Lumira Ventures

Since Bright Angel Therapeutics was founded in 2017, it has participated in 1 round of funding. In total Bright Angel Therapeutics has raised $0. Bright Angel Therapeutics' funding round was on Dec 2019 for a total of $0

Investments

No recent investments found related to Bright Angel Therapeutics

Bright Angel Therapeutics News

Social Media

Headquarters

-

Toronto, OntarioM4B 1B5

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Bright Angel Therapeutics focuses on the development of novel drugs for the treatment of drug-resistant and fungal infections. Bright Angel Therapeutics was founded in 2017. Bright Angel Therapeutics' headquarters is located in Toronto, Ontario, CA M4...

CEO

Bright Angel Therapeutics's President & CEO, Dominic Jaikaran, currently has an approval rating of 90%. Bright Angel Therapeutics's primary competitors are Cidara, Amplyx & Scynexis.

Website

brightangeltherapeutics.com

Frequently Asked Questions about Bright Angel Therapeutics

  1. When was Bright Angel Therapeutics founded?

    Bright Angel Therapeutics was founded in 2017
  2. Who is Bright Angel Therapeutics's CEO?

    Bright Angel Therapeutics's CEO is Dominic Jaikaran
  3. How much revenue does Bright Angel Therapeutics generate?

    Bright Angel Therapeutics generates $ < 1M in revenue
  4. How much funding does Bright Angel Therapeutics have?

    Bright Angel Therapeutics has historically raised $0 in funding
  1. Where is Bright Angel Therapeutics's headquarters?

    Bright Angel Therapeutics's headquarters is in Toronto Ontario, CA
  2. How many employees does Bright Angel Therapeutics have?

    Bright Angel Therapeutics has 9 employees
  3. What sector does Bright Angel Therapeutics operate in?

    Bright Angel Therapeutics is in Biotechnology
  4. Who are Bright Angel Therapeutics's competitors?

    Bright Angel Therapeutics's top competitors are Cidara, Amplyx, Scynexis